摘要
目的探讨99Tcm-甲氧基异丁基异腈(MIBI)腺苷负荷门控心肌灌注显像(G-MID在经皮冠状动脉介入治疗(PCI)术前后的l临床应用价值。方法对54例行PCI的冠心病患者,术前2周行99Tcm-MIBI腺苷负荷+静息G—MPI,并随访6个月,于PCI术后1个月、6个月复查腺苷负荷+静息G-MPI显像。采用左心室20个节段0~4分的5分制半定量评分方法,分别计算每个室壁节段的腺苷负荷评分(SS)及静息评分(RS),两者的差值为差分值(DS),用于评估缺血的程度。综合每个节段腺苷负荷-静息G—MPI的评分,将其结果分为可逆性缺血(RD)和固定缺损(FD)。采用SPSS11.5软件,计量资料行独立样本t检验,计数资料行x2检验。结果(1)PCI术前根据心肌显像灌注异常节段划分,共有435个节段异常(RD、FD分别为323和112个),术后1个月312个节段RD改善,62个节段FD改善,PCI术后1个月RD的改善率(96.59%)明显好于FD(55.36%),差异有统计学意义(x2=117.30,P〈0.01);术后6个月有12个节段进一步改善(RD3个、FD9个),术后6个月RD改善较FD明显,两者差异有统计学意义(97.52%与63.39%,x2=96.919,P〈0.01)。(2)PCI术前RD、FD的SS分别为3.31±0.624和3.64±0.487,术后1个月分别为1.69±0.668和3.14±0.683,术后6个月分别为1.39±0.728和3.03±0.506,术前与术后1个月RD、FD的SS差异有统计学意义,t=10.569,2.348,P均〈0.05;术前与术后6个月RD、FD的SS差异有统计学意义,t=11.991,2.720,P均〈0.05;术后1个月与术后6个月RD、FD的sS差异无统计学意义,t=1.885,0.784,P=0.068,0.435。结论G-MPI对PCI术有一定的指导意义并可较好地评价PCI术疗效。
Objective To investigate the clinical value of 99Tcm-methoxyisobutylisonitrile (MIBI) adenosine (ADE) stress gated myocardial perfusion imaging (G-MPI) during percutaneous coronary intervention (PCI). Methods Fifty-four coronary heart disease (CHD) patients had the ADE stress and rest G-MPI at two weeks before, and 1 month, 6 months after PCI. A semi-quantitative visual analysis using a 20-segment and 5-point scoring system was used in both stress (SS) and rest (RS). SPSS 11.5 was used for data analysis. The measurement data were performed with the independent samples t-test and enumeration data withx2-test. Results (1) Segmental based analyses, a total of 435 abnormal segments were found before PCI: 323 were reversible defect (RD) and 112 were fixed defect (FD). One month after PCI, 374 segments improved. Three hundred and twelve were RD and 62 were FD (96.59% vs 55.36%, X2 = 117.30, P 〈0. 01 ). An additional 12 segments were improved 6 months after PCI. Three were RD and 9 were FD (97.52% vs 63.39%, x2=96.919, P 〈 0.01 ). (2) There was significant difference of SS in RD and FD in patients before and one month after PCI (3.31 ± 0.624 vs 1.69 ±0. 668, t = 10. 569, P 〈 0. 05 and 3.64 ±0. 487 vs 3.14 ±0. 683, t = 2. 348, P 〈 0. 05 ), and before and six months after PCI (3.31 ±0.624 vs 1.39 ±0.728, t =11.991, P〈0.05 and 3.64 ±0.487 vs 3.03 ±0.506, t =2. 720, P〈 0. 05), respectively. No significant difference was noted at one month and six months after PCI ( 1.69 ± 0.668 vs 1.39 ±0. 728, t = 1. 885, P = 0. 068 and 3.14 ± 0. 683 vs 3.03 ± 0. 506,,t = 0. 784, P = 0. 435), respectively. Conclusion G-MPI can provide useful information to predict outcome of PCI at one month after intervention.
出处
《中华核医学杂志》
CAS
CSCD
北大核心
2010年第2期125-128,共4页
Chinese Journal of Nuclear Medicine
基金
基金项目:宁夏自然科学基金(NZ0796)